- Home
- DAL vs TAK Comparison
DAL vs TAK Comparison
Compare DAL & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAL
- TAK
- Stock Information
- Founded
- DAL 1924
- TAK 1781
- Country
- DAL United States
- TAK Japan
- Employees
- DAL N/A
- TAK N/A
- Industry
- DAL Air Freight/Delivery Services
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- DAL Consumer Discretionary
- TAK Health Care
- Exchange
- DAL Nasdaq
- TAK Nasdaq
- Market Cap
- DAL 41.3B
- TAK 43.9B
- IPO Year
- DAL N/A
- TAK N/A
- Fundamental
- Price
- DAL $64.04
- TAK $13.63
- Analyst Decision
- DAL Strong Buy
- TAK
- Analyst Count
- DAL 13
- TAK 0
- Target Price
- DAL $71.22
- TAK N/A
- AVG Volume (30 Days)
- DAL 8.1M
- TAK 1.3M
- Earning Date
- DAL 01-10-2025
- TAK 10-31-2024
- Dividend Yield
- DAL 0.94%
- TAK 4.65%
- EPS Growth
- DAL 35.88
- TAK 49.73
- EPS
- DAL 7.20
- TAK 1.27
- Revenue
- DAL $60,307,000,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- DAL N/A
- TAK $4.41
- Revenue Next Year
- DAL $6.07
- TAK $1.09
- P/E Ratio
- DAL $8.90
- TAK $21.56
- Revenue Growth
- DAL 5.32
- TAK 9.43
- 52 Week Low
- DAL $35.46
- TAK $12.58
- 52 Week High
- DAL $66.25
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- DAL 70.10
- TAK 39.22
- Support Level
- DAL $56.81
- TAK $13.46
- Resistance Level
- DAL $66.25
- TAK $13.75
- Average True Range (ATR)
- DAL 1.89
- TAK 0.16
- MACD
- DAL 0.33
- TAK -0.01
- Stochastic Oscillator
- DAL 80.99
- TAK 21.15
About DAL Delta Air Lines Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.